Latest Content

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use with JAK inhibitors.

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

FDA OKs Keytruda with paclitaxel for PD-L1 positive, platinum-resistant ovarian, fallopian tube or peritoneal cancers, improving survival and delaying growth.

Charles Walker joins CURE’s Gina Mauro to share his long and road to a liver cancer diagnosis and the importance of being your own medical advocate.

Former NFL player and advocate Chris Draft urges patients with cancer to recognize small actions, learn terms and stay engaged to rebuild confidence after diagnosis.

Amid the grief that I have and continue to deal with due to my sister’s death from cancer, I have been blessed with phenomenal support.

The FDA granted fast track designation to irpagratinib for previously treated advanced hepatocellular carcinoma with FGF19 overexpression.

The U.S. FDA granted “study may proceed” clearance for a trial of teverelix in patients with advanced prostate cancer and high cardiovascular risk.

CURE spoke with breast cancer survivor Mary Royal about her cancer journey in a multi-part interview.

Most people think of anniversaries as happy things. But there are other anniversaries that commemorate less pleasant events. Some anniversaries are a mix of pleasant and unpleasant.

In a recent CURE conversation, Charles Walker shared how months of unexplained fatigue and back pain ultimately led to a life-altering diagnosis.

CURE spoke with Dr. Kathie-Ann Joseph about the importance of personalized, multidisciplinary treatments when caring for patients with breast cancer.